FMR1 and fragile X syndrome: Analysis of the methylation profiles of the CRISPR cut FXS iPSC clonal lines at the FMR1 promoter regions revealed that the non-reactivated clonal lines remained highly methylated as the uncut FXS iPS cells (Fig 4B).